Investments, Funding & Disinvestment
-
Novo Nordisk invests USD470M to expand GLP-1 tablet production in Ireland
The tabletting facility in Athlone represents a cornerstone of Novo Nordisk’s long-term strategy to strengthen its presence in Ireland and enhance its global manufacturing footprint.
-
Investcorp supports Middle East’s first CAR-T therapy center through a Chinese healthcare partnership
This advanced immunotherapy works by modifying a patient’s own immune cells to better identify and destroy cancer cells.
-
Novo Nordisk collaborates with Vivtex to develop oral biologic medicines for obesity
The agreement grants Novo Nordisk licensing rights to select oral drug-delivery technologies from Vivtex.
-
Saudi Arabia to host landmark life sciences summit as CPHI, BIO Middle East collaborate in Riyadh
Saudi Arabia’s pharmaceutical market projects growth to USD15.6 billion by 2030, up from USD11.8 billion in 2024.
-
Dubai’s GluCare.Health rebrands as Metabolic to tackle interconnected health conditions
The rebrand responds to growing scientific understanding that metabolic syndrome functions as a multi-system condition rather than isolated diseases.
-
-
Egypt’s first AI-powered radiotherapy system debuts in Upper Egypt through Arab African International partnership
As part of AAIB’s corporate social responsibility efforts, the system draws on cutting-edge global oncology technology.
-
Johnson & Johnson commits USD55B to US manufacturing expansion amid tariff concerns
The new facility will generate approximately 500 permanent biomanufacturing positions once operational.
-
Scinai acquires Recipharm’s Israeli API facility in strategic CDMO partnership
Scinai will retain the plant’s entire workforce as it integrates the facility into its CDMO operations.
-
AbbVie invests USD380M in Illinois manufacturing facilities to increase API production
AbbVie plans to hire 300 new employees for the facilities, targeting engineers, scientists, manufacturing operators, and lab technicians in the North Chicago area.